IFI16 Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">IFI16 Protein</th>
</tr>
<tr>
<td class="label">Signal</td>
<td>Location</td>
</tr>
<tr>
<td class="label">NLS1</td>
<td>Amino acids 215-230</td>
</tr>
<tr>
<td class="label">NLS2</td>
<td>Amino acids 400-415</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">ASC/PYCARD</td>
<td>PYD domain</td>
</tr>
<tr>
<td class="label">AIM2</td>
<td>Collaboration</td>
</tr>
<tr>
<td class="label">Caspase-1</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">Pro-IL-1β</td>
<td>Cleavage</td>
</tr>
<tr>
<td class="label">Pro-IL-18</td>
<td>Cleavage</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Transcriptional regulation</td>
</tr>
<tr>
<td class="label">ATM</td>
<td>DNA damage sensing</td>
</tr>
<tr>
<td class="label">BRCA1</td>
<td>Chromatin regulation</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">cGAS</td>
<td>Cross-talk</td>
</tr>
<tr>
<td class="label">[STING](/proteins/sting-protein)</td>
<td>Cross-talk</td>
</tr>
<tr>
<td class="label">TBK1</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Neurons](/entities/neurons)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Microglia](/entities/microglia)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Endothelial cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>
Introduction
Interferon Gamma Inducible Protein 16 (IFI16) is a nuclear DNA sensor that plays critical roles in innate immunity, inflammasome assembly, and transcriptional regulation. As a member of the HIN-200 (Hemopoietic Interferon-Inducible Nuclear) protein family, IFI16 can detect foreign and aberrant DNA in the nucleus and initiate inflammatory responses. In the context of neurodegenerative diseases, IFI16 has emerged as an important player in chronic neuroinflammation, with elevated expression and inflammasome activation observed in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other disorders. [@ifi]
Official Symbol: IFI16 [@ifia]
Official Full Name: Interferon Gamma Inducible Protein 16 [@ifib]
Molecular Weight: ~82 kDa (729 amino acids) [@ific]
Cellular Location: Predominantly nucleus (nucleolus and nuclear speckles) [@nuclear]
Gene: IFI16 (Chromosome 1q23.1) [@ifid]
UniProt ID: Q16644
Overview
IFI16 is expressed in various cell types, including immune cells (macrophages, dendritic cells, lymphocytes), endothelial cells, and structural cells. In the central nervous system, IFI16 is expressed in neurons, astrocytes, [microglia](/cell-types/microglia-neuroinflammation), and oligodendrocytes. Its dual role as a DNA sensor and transcriptional regulator makes it uniquely positioned to link DNA damage sensing to inflammatory responses.
Unlike other DNA sensors like cGAS (which localizes to the cytoplasm), IFI16 operates primarily in the nucleus, where it can detect:
- Foreign viral DNA
- Aberrant host DNA (e.g., from DNA damage)
- Mitochondrial DNA released into the nucleus
- Chromatin alterations
Protein Structure
IFI16 contains several distinct structural domains:
HIN-A Domain
- Located at the N-terminus (amino acids 1-200)
- Binds double-stranded DNA
- Contains the interferon-stimulated gene (ISG) domain
- Calcium-dependent DNA binding
HIN-B Domain
- Located in the middle region (amino acids 340-500)
- Also binds double-stranded DNA
- Cooperates with HIN-A for DNA binding
- Mediates protein-protein interactions
PYD Domain (Pyrin Domain)
- Located at the C-terminus (amino acids 700-729)
- Mediates homotypic protein-protein interactions
- Part of the pyrin inflammasome family
- Interacts with ASC adaptor protein
Nuclear Localization Signals
Oligomerization Properties
- IFI16 can form trimers and higher-order oligomers
- Oligomerization enhanced upon DNA binding
- Necessary for inflammasome assembly
Molecular Function
DNA Sensing
IFI16 functions as a nuclear DNA sensor:
DNA Binding
- Binds double-stranded DNA via HIN domains
- Prefers DNA >500 bp in length
- Calcium enhances DNA binding affinity
Oligomerization
- DNA binding induces oligomerization
- Forms filament-like structures on DNA
- Creates signaling platforms
Signal Transduction
- Recruits ASC adaptor protein via PYD
- Initiates inflammasome assembly
- Activates caspase-1
Inflammasome Formation
- IFI16 inflammasome activated by nuclear DNA
- Distinct from AIM2 inflammasome (cytoplasmic)
- Requires ASC and caspase-1
Inflammasome Activation
The IFI16 inflammasome pathway:
Nuclear DNA detected by IFI16
IFI16 oligomerizes on DNA
PYD domain recruits ASC via PYD-PYD interaction
ASC recruits pro-caspase-1
Caspase-1 auto-cleaves and activates
Active caspase-1 cleaves pro-IL-1β and pro-IL-18
Mature cytokines releasedTranscriptional Regulation
Beyond inflammasome activation, IFI16:
p53 Regulation
- Binds to p53 response elements
- Modulates p53 transcriptional activity
- Links DNA damage to inflammation
STAT1 Regulation
- Interacts with STAT1
- Modulates interferon-stimulated genes
- Affects cell proliferation
RBP-Jκ Regulation
- Interacts with RBP-Jκ transcription factor
- Modulates Notch signaling
- Affects cell differentiation
Pathway Interactions
Inflammasome Pathway
DNA Damage Response
Innate Immune Signaling
Role in Neurodegeneration
Alzheimer's Disease
IFI16 plays a significant role in AD pathogenesis:
Inflammasome Activation
- IFI16 inflammasome activated in AD brain
- Co-localizes with [amyloid-beta](/proteins/amyloid-beta) plaques
- Elevated caspase-1 and IL-1β in AD tissue
- Contributes to chronic neuroinflammation
DNA Damage Sensing
- Neuronal DNA damage accumulates in AD
- IFI16 detects damaged nuclear DNA
- Links DNA damage response to inflammation
Microglial Activation
- IFI16 in microglia around plaques
- Perpetuates inflammatory response
- May impair Aβ clearance
Therapeutic Implications
- IFI16 inflammasome inhibition
- Downstream cytokine blockade
- DNA damage repair enhancement
Parkinson's Disease
In PD, IFI16 contributes to dopaminergic neuron loss:
[α-Synuclein](/proteins/alpha-synuclein)-Mediated Activation
- α-Suclein aggregates may cause nuclear DNA abnormalities
- IFI16 detects aberrant DNA
- Activates inflammasome in neurons and glia
Microglial Inflammasome
- IFI16 in substantia nigra microglia
- Enhanced IL-1β production
- Contributes to neuroinflammation
LRRK2 Interaction
- LRRK2 affects inflammasome regulation
- Links genetic risk to inflammation
Amyotrophic Lateral Sclerosis
IFI16 in ALS:
Motor Neuron Vulnerability
- IFI16 inflammasome in motor neurons
- [TDP-43](/proteins/tdp-43) pathology associated with IFI16
- Contributes to inflammatory cell death
Astrocyte Activation
- IFI16 in astrocytes
- Non-cell autonomous toxicity
- Inflammatory milieu
Therapeutic Target
- Inflammasome inhibitors
- IL-1β neutralization
Other Neurodegenerative Conditions
- Huntington's Disease: IFI16 in striatal neurons
- Multiple Sclerosis: IFI16 in demyelination
- Frontotemporal Dementia: IFI16 dysregulation
Expression in the Brain
Therapeutic Targeting
Small Molecule Inhibitors
Inflammasome Inhibitors
- Target ASC-IFI16 interaction
- Block caspase-1 activation
- Reduce IL-1β production
Cytokine Blockade
- IL-1β neutralizing antibodies
- IL-18 neutralizing antibodies
- Receptor antagonists
DNA Damage Repair
- Enhance DNA repair pathways
- Reduce IFI16 activation
- Neuroprotective
Biological Approaches
Antisense Oligonucleotides
- Reduce IFI16 expression
- Cell-type specific delivery
Gene Therapy
- Conditional knockdown
- Tissue-specific approaches
Challenges
- IFI16 has protective antiviral functions
- Balancing inflammation and immunity
- Cell-type specific targeting needed
- [Blood-brain barrier](/entities/blood-brain-barrier) penetration
Research Directions
Current research focuses on:
Biomarkers
- IFI16 levels in CSF
- Inflammasome markers
- Cytokine profiles
Cell-Specific Mechanisms
- Neuron-specific IFI16 functions
- Microglial IFI16 in disease
Therapeutic Development
- Optimized inflammasome inhibitors
- Targeted delivery
History
Key milestones in IFI16 research:
- 1995: IFI16 identified as interferon-stimulated gene
- 2000s: DNA sensor function discovered
- 2010s: Inflammasome role established
- 2020s: Link to neurodegeneration explored
Background
The study of Ifi16 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- IFI16 Gene
- AIM2 Gene
- ASC Gene
- [NLRP3 Inflammasome](/mechanisms/nlrp3-inflammasome) cGAS-STING Pathway
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [DNA Damage Response](/mechanisms/dna-damage-response)